@misc{indiciaec2166bb8b5c6,
  title = {Efficacy and Safety of Once-Weekly Semaglutide 2.0\&\#x2009;mg as an Add-On to Dose-Reduced Insulin Glargine versus Dose-Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE).},
  author = {Helena W Rodbard and Concetta Irace and Jevitha Lobo and Konstantinos Makrilakis and Prachi Priyadarshini and Suvanjaa Sivalingam and Santiago Tof\&\#xe9; Povedano and Anuj Bhargava},
  year = {2026},
  doi = {10.1111/dom.71132},
  url = {https://pubmed.ncbi.nlm.nih.gov/42504064/},
  note = {Source identifier: 42504064}
}